A Randomized Phase 2 Study of Erenumab for the Prevention of Episodic Migraine in Japanese Adults

OBJECTIVE: A phase 2, double‐blind, placebo‐controlled study to evaluate the efficacy and safety of erenumab for the prevention of episodic migraine in Japanese patients was conducted. BACKGROUND: Previous global clinical studies have demonstrated the efficacy of erenumab in the prevention of migrai...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Headache
Hlavní autoři: Sakai, Fumihiko, Takeshima, Takao, Tatsuoka, Yoshihisa, Hirata, Koichi, Lenz, Robert, Wang, Yi, Cheng, Sunfa, Hirama, Toshiyasu, Mikol, Daniel D.
Médium: Artigo
Jazyk:Inglês
Vydáno: John Wiley and Sons Inc. 2019
Témata:
Research Submissions
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6900095/
https://ncbi.nlm.nih.gov/pubmed/31612482
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/head.13652
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky